Search
Aardvark Therapeutics Inc
AARDAdd to Watchlist
5.700USD
+0.080+1.42%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
124.35MMarket Cap
LossP/E TTM
Aardvark Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-2.93
-204.81%
Analyst Rating
BUY
2026-07-02
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its current assets were 111.89M, with a year-on-year change of 50.92.
What are the total assets of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its total assets of Aardvark Therapeutics Inc were 117.18M, with a year-on-year change of 51.19.
What are the total liabilities of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its total liabilities of Aardvark Therapeutics Inc were 10.55M, with a year-on-year change of 95.55.
What is the total equity of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its total equity of Aardvark Therapeutics Inc was 106.63M, with a year-on-year change of 47.87.
What is the net investment of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its net investment of Aardvark Therapeutics Inc was -49.67M, with a year-on-year change of -313.96.
What is the net financing of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its net financing of Aardvark Therapeutics Inc was 89.25M, with a year-on-year change of 8.85.
What is the Earnings Per Share (EPS) of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.93, with a year-on-year change of -204.81.
What is the Return on Assets (ROA) of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -59.16, with a year-on-year change of -26.50.
What is the operating profit of Aardvark Therapeutics Inc?
According to Aardvark Therapeutics Inc's FY2025 earnings report, its operating profit was -62.73M, with a year-on-year change of -175.29.